Rafferty Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $9.34M | Sell |
|
|||||
|
2023
Q3 | $10.9M | Buy |
|
|||||
|
2023
Q2 | $7.9M | Buy |
|
|||||
|
2023
Q1 | $6.45M | Sell |
|
|||||
|
2022
Q4 | $8.75M | Buy |
|
|||||
|
2022
Q3 | $5.71M | Buy |
|
|||||
|
2022
Q2 | $4.34M | Sell |
|
|||||
|
2022
Q1 | $5.44M | Buy |
|
|||||
|
2021
Q4 | $5.74M | Buy |
|
|||||
|
2021
Q3 | $3.33M | Buy |
|
|||||
|
2021
Q2 | $2.45M | Sell |
|
|||||
|
2021
Q1 | $3M | Buy |
|
|||||
|
2020
Q4 | $859K | Sell |
|
|||||
|
2020
Q3 | $2.49M | Buy |
|
|||||
|
2020
Q2 | $1.06M | Buy |
|
|||||
|
2020
Q1 | $316K | Sell |
|
|||||
|
2019
Q4 | $4.5M | Sell |
|
|||||
|
2019
Q3 | $5.9M | Buy |
|
|||||
|
2019
Q2 | $5.4M | Sell |
|
|||||
|
2019
Q1 | $5.24M | Buy |
|